Samples of Sources
from YourStream
Medscape MobiHealthNews
Medscape Headlines
Medscape MobiHealthNews
medscape headlines
Below are a few samples from the source, Medscape Headlines .
To see the full set of articles, you must become a YourStream subscriber.
Triplet Regimen Boosts Survival in Metastatic Melanoma, but at a Cost
For patients with metastatic melanoma, triplet therapy with atezolizumab and vemurafenib plus cobimetinib provides significant survival benefits, but the regimen may not be cost-effective, researchers say.
1 day ago

Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment
Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance olaparib therapy, a clinical trial analysis suggests.
1 day ago

What's Hot at the World's Premiere Breast Cancer Meeting
Carlos Arteaga, MD, highlights research with potentially "practice-changing implications" coming out of the San Antonio Breast Cancer Symposium this December.
1 day ago